NovMetaPharma Co., Ltd.
Develops first-in-class drugs and supplements for metabolic and fibrotic diseases.
229500 | KO
Overview
Corporate Details
- ISIN(s):
- KR7229500004
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 언주로 727 13층 (논현동, 트리스빌딩), 강남구
- Website:
- http://www.novmeta.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NovMetaPharma Co., Ltd. is a biopharmaceutical company specializing in the research, development, and commercialization of first-in-class drugs for metabolic and fibrotic diseases. The company focuses on creating novel treatments with differentiated mechanisms to address significant unmet medical needs. Its core pipeline includes therapeutic candidates for conditions such as type 2 diabetes, obesity, chronic kidney disease, and fibrosis, with lead assets including Cyclo-Z and CHP. In addition to its primary focus on drug development, the company also develops health supplements and sells related raw materials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-15 00:00 |
Regulatory News Service
기업설명회(IR)개최결과
|
Korean | 6.6 KB | ||
| 2025-05-13 00:00 |
Regulatory News Service
특허권취득(자율공시)
|
Korean | 4.8 KB | ||
| 2025-04-29 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2025-03-31 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 170.5 KB | ||
| 2025-03-25 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.3 KB | ||
| 2025-03-24 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 20.3 KB | ||
| 2025-03-24 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 22.1 KB | ||
| 2025-03-14 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 361.6 KB | ||
| 2025-03-13 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 9.4 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 11.0 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 238.9 KB | ||
| 2025-03-06 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 66.1 KB | ||
| 2025-02-05 00:00 |
Regulatory News Service
특허권취득(자율공시)
|
Korean | 5.6 KB | ||
| 2024-12-20 00:00 |
Report Publication Announcement
기업설명회(IR)개최결과
|
Korean | 6.7 KB | ||
| 2024-12-17 00:00 |
Regulatory News Service
특허권취득(자율공시)
|
Korean | 6.1 KB |
Automate Your Workflow. Get a real-time feed of all NovMetaPharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NovMetaPharma Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NovMetaPharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
